Summary
This prediction ended on 10.03.24 with a price of €9.67. The price of Altimmune has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.02%. HC_Wainwright has a follow-up prediction for Altimmune where he still thinks Altimmune is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altimmune | 23.661% | 23.661% | -37.429% | -38.170% |
| iShares Core DAX® | 4.642% | 7.489% | 6.987% | 53.734% |
| iShares Nasdaq 100 | 4.471% | 16.803% | 40.281% | 104.329% |
| iShares Nikkei 225® | 7.670% | 16.856% | 47.874% | 73.793% |
| iShares S&P 500 | 2.472% | 9.903% | 28.430% | 72.579% |
Comments by HC_Wainwright for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Ratings data for ALT provided by MarketBeat
In the thread Trading Altimmune
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten